| 杨元素,徐杨妮,谢学建.2011—2015年某院静脉药物配置中心化疗止吐药用药分析[J].安徽医药,2017,21(11):2103-2106. |
| 2011—2015年某院静脉药物配置中心化疗止吐药用药分析 |
| Analysis of application of anti-vomiting medicine for actinotheraphy or chemotheraphy in PIVAS during the period of 2011—2015 |
| 投稿时间：2016-09-22 |
| DOI： |
| 中文关键词: 静脉配置中心 化疗止吐药 用药分析 |
| 英文关键词: PRIVAS Chemotherapy antiemetic drugs Analysis of drugs |
| 基金项目: |
|
| 摘要点击次数: 2300 |
| 全文下载次数: 707 |
| 中文摘要: |
| 目的 通过评价该院2011—2015年静脉配置中心化疗止吐药的使用情况,为临床合理使用化疗止吐药提供参考。方法搜集该院2011—2015年化疗止吐药的用药数据,根据限定日剂量法、销售金额排序法、用药频度分析法进行统计分析。结果 5-羟色胺3受体拮抗剂用药金额逐年增长,社会效益和经济效益同步性越来越好,多巴胺受体拮抗剂临床使用量基本不变。结论 该院静脉配置中心化疗止吐药使用符合社会发展和人们的需要,用药基本合理。 |
| 英文摘要: |
| Objective To evaluate the use of chemotherapy antiemetic drugs in our hospital configuration center venous from 2011 to 2015 and to provide reference for clinical rational use of chemotherapy antiemetic drugs. Methods The data of chemotherapy antiemetic drugs during 2011 to 2015 in Nanjing General Hospital of Nanjing Military Area Command were collected according to the daily dose limit method,the sales amount of sorting method,frequency analysis method for statistical analysis. Results 5-HT3 receptor antagonist medicine amount increased year by year,social benefit and economic benefit synchronicity are getting better and better,the dopamine receptor antagonist clinical usage basically remain unchanged. Conclusions Our configuration center venous chemotherapy antiemetic drugs use are in line with the social development and the needs of the people and rational. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
